The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Classification System: A Taxonomy for Young Women With Acute Myocardial Infarction
Overview
Authors
Affiliations
Background: Current classification schemes for acute myocardial infarction (AMI) may not accommodate the breadth of clinical phenotypes in young women.
Methods And Results: We developed a novel taxonomy among young adults (≤55 years) with AMI enrolled in the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study. We first classified a subset of patients (n=600) according to the Third Universal Definition of MI using a structured abstraction tool. There was heterogeneity within type 2 AMI, and 54 patients (9%; including 51 of 412 women) were unclassified. Using an inductive approach, we iteratively grouped patients with shared clinical characteristics, with the aims of developing a more inclusive taxonomy that could distinguish unique clinical phenotypes. The final VIRGO taxonomy classified 2802 study participants as follows: class 1, plaque-mediated culprit lesion (82.5% of women; 94.9% of men); class 2, obstructive coronary artery disease with supply-demand mismatch (2a: 1.4% women; 0.9% men) and without supply-demand mismatch (2b: 2.4% women; 1.1% men); class 3, nonobstructive coronary artery disease with supply-demand mismatch (3a: 4.3% women; 0.8% men) and without supply-demand mismatch (3b: 7.0% women; 1.9% men); class 4, other identifiable mechanism (spontaneous dissection, vasospasm, embolism; 1.5% women, 0.2% men); and class 5, undetermined classification (0.8% women, 0.2% men).
Conclusions: Approximately 1 in 8 young women with AMI is unclassified by the Universal Definition of MI. We propose a more inclusive taxonomy that could serve as a framework for understanding biological disease mechanisms, therapeutic efficacy, and prognosis in this population.
Zhang S, Chu L, Lu Y, Wei J, Dubrow R, Chaudhry S Geohealth. 2025; 9(2):e2024GH001234.
PMID: 39968338 PMC: 11833228. DOI: 10.1029/2024GH001234.
Type 2 myocardial infarction: challenges in diagnosis and treatment.
Chapman A, Taggart C, Boeddinghaus J, Mills N, Fox K Eur Heart J. 2024; 46(6):504-517.
PMID: 39658094 PMC: 11804249. DOI: 10.1093/eurheartj/ehae803.
Manzo-Silberman S, Couturaud F, Bellemain-Appaix A, Vautrin E, Gompel A, Drouet L J Am Heart Assoc. 2024; 13(19):e034456.
PMID: 39319493 PMC: 11681485. DOI: 10.1161/JAHA.124.034456.
Lin C, McCarthy C, Mohebi R, Liu Y, Blankstein R, Murphy S JACC Adv. 2024; 3(2):100795.
PMID: 38939381 PMC: 11198490. DOI: 10.1016/j.jacadv.2023.100795.
Spectrum of Ischemic Heart Disease Throughout a Woman's Life Cycle.
Narayana Gowda S, Garapati S, Kurrelmeyer K Methodist Debakey Cardiovasc J. 2024; 20(2):81-93.
PMID: 38495657 PMC: 10941714. DOI: 10.14797/mdcvj.1331.